Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.82%) $83.16
Gas
(-1.16%) $1.619
Gold
(-0.47%) $2 336.10
Silver
(-0.13%) $27.50
Platinum
(0.54%) $927.10
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.21%) $11.00
USD/GBP
(-0.25%) $0.798
USD/RUB
(0.00%) $92.17

Sanntidsoppdatering for Cansino Biologics Inc [6185.HK]

Børs: HKSE Sektor: Pharmaceuticals Industri: Drug Manufacturers—Specialty & Generic
Sist oppdatert29 apr 2024 @ 04:57
25% discount on Stockinvest.us - Use code: Podcast

2.55% HKD 19.30

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 04:57):

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N...

Stats
Dagens volum 867 100
Gjennomsnittsvolum 1.09M
Markedsverdi 7.15B
EPS HKD-0.580 ( 2023-10-30 )
Last Dividend HKD0.937 ( 2022-07-13 )
Next Dividend HKD0 ( N/A )
P/E -2.97
ATR14 HKD0.0430 (0.22%)

Volum Korrelasjon

Lang: 0.31 (neutral)
Kort: 0.79 (moderate)
Signal:(63.663) Neutral

Cansino Biologics Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Cansino Biologics Inc Korrelasjon - Valuta/Råvare

The country flag -0.33
( neutral )
The country flag -0.27
( neutral )
The country flag 0.00
( neutral )
The country flag -0.05
( neutral )
The country flag 0.19
( neutral )
The country flag 0.44
( neutral )

Cansino Biologics Inc Økonomi

Annual 2023
Omsetning: HKD357.08M
Bruttogevinst: HKD-443.75M (-124.27 %)
EPS: HKD-6.01
FY 2023
Omsetning: HKD357.08M
Bruttogevinst: HKD-443.75M (-124.27 %)
EPS: HKD-6.01
FY 2022
Omsetning: HKD1.03B
Bruttogevinst: HKD-186.61M (-18.10 %)
EPS: HKD-3.91
FY 2021
Omsetning: HKD4.30B
Bruttogevinst: HKD3.00B (69.85 %)
EPS: HKD7.74

Financial Reports:

No articles found.

Cansino Biologics Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.937
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A) 		HKD0
(N/A)

Cansino Biologics Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.937 2022-07-13
Last Dividend HKD0.937 2022-07-13
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out HKD0.937 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
HKD0 Estimate 0.00 %
Dividend Stability
0.04 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2377.HK Ex Dividend Junior 2023-06-15 Annually 0 0.00%
1358.HK Ex Dividend Junior 2023-09-29 Annually 0 0.00%
0400.HK Ex Dividend Junior 2023-06-13 Sporadic 0 0.00%
6699.HK Ex Dividend Knight 2023-07-03 Annually 0 0.00%
1907.HK Ex Dividend Junior 2023-09-08 Semi-Annually 0 0.00%
0939.HK Ex Dividend Knight 2023-07-06 Annually 0 0.00%
0064.HK Ex Dividend Knight 2023-08-29 Semi-Annually 0 0.00%
2886.HK Ex Dividend Junior 2023-05-19 Annually 0 0.00%
1503.HK Ex Dividend Junior 2023-09-13 Semi-Annually 0 0.00%
0553.HK Ex Dividend Junior 2023-07-03 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-4.101.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.1591.200-5.30-6.36[0 - 0.3]
returnOnEquityTTM-0.2521.500-3.91-5.86[0.1 - 1]
payoutRatioTTM-0.0603-1.000-0.6030.603[0 - 1]
currentRatioTTM2.020.8004.903.92[1 - 3]
quickRatioTTM1.8580.8003.783.02[0.8 - 2.5]
cashRatioTTM1.1001.5005.007.50[0.2 - 2]
debtRatioTTM0.283-1.5005.29-7.93[0 - 0.6]
interestCoverageTTM-77.501.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-3.622.00-1.207-2.41[0 - 30]
freeCashFlowPerShareTTM-6.102.00-3.05-6.10[0 - 20]
debtEquityRatioTTM0.500-1.5008.00-10.00[0 - 2.5]
grossProfitMarginTTM-0.1701.000-6.17-6.17[0.2 - 0.8]
operatingProfitMarginTTM-3.571.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.3381.000-2.99-2.99[0.2 - 2]
assetTurnoverTTM0.03880.800-3.07-2.46[0.5 - 2]
Total Score-3.31

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.891.000-0.3930[1 - 100]
returnOnEquityTTM-0.2522.50-2.51-5.86[0.1 - 1.5]
freeCashFlowPerShareTTM-6.102.00-2.03-6.10[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.622.00-1.207-2.41[0 - 30]
payoutRatioTTM-0.06031.500-0.6030.603[0 - 1]
pegRatioTTM0.1031.500-2.650[0.5 - 2]
operatingCashFlowSalesRatioTTM-2.461.000-10.000[0.1 - 0.5]
Total Score-2.80

Cansino Biologics Inc

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. In addition, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB015 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.